PROGENICS PHARMACEUTICALS INC (PGNX) has 23 open-market insider trades by 14 insiders since 2006. The most active filer is Mark Robert Baker, CEO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Broadfin Capital, LLC | 10% Owner | — | 2 | $11.2M | 2017-02-15 |
| Kevin Kotler | 10% | — | 1 | $7.5M | 2014-07-21 |
| Velan Capital, L.P. | 10% Owner | — | 1 | $4.6M | 2019-09-04 |
| Balaji Venkataraman | 10% Owner | — | 1 | $1.4M | 2019-08-26 |
| Altiva Management Inc. | 10% Owner | — | 1 | $719K | 2019-09-09 |
| Paul F. Jacobson | Dir | — | 2 | $618K | 2008-10-23 |
| LTE Management, LLC | 10% Owner | — | 1 | $614K | 2019-09-09 |
| Kurt W. Briner | Dir | — | 2 | $502K | 2012-02-03 |
| Paul J. Maddon | CEO | — | 3 | $391K | 2010-12-01 |
| Robert J. Israel | PresMedi | — | 2 | $263K | 2015-06-11 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Altiva Management Inc. | 10% Owner | Buy | $719K | 2019-09-09 |
| LTE Management, LLC | 10% Owner | Buy | $614K | 2019-09-05 |
| Velan Capital, L.P. | 10% Owner | Buy | $4.6M | 2019-09-03 |
| Balaji Venkataraman | 10% Owner | Buy | $1.4M | 2019-08-23 |
| Broadfin Capital, LLC | 10% Owner | Sell | $7.8M | 2017-02-13 |
| Broadfin Capital, LLC | 10% Owner | Sell | $3.4M |
Companies that share insiders with PGNX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2017-02-07 |
| Robert J. Israel | President & Medi | Sell | $14K | 2015-06-11 |
| Robert J. Israel | President & Medi | Sell | $21K | 2015-03-13 |
| Robert J. Israel | President & Medi | Sell | $14K | 2015-03-11 |
| Robert J. Israel | President & Medi | Sell | $32K | 2015-03-03 |
| Robert J. Israel | President & Medi | Sell | $14K | 2015-01-12 |
| Robert J. Israel | President & Medi | Sell | $21K | 2014-12-11 |
| Robert J. Israel | President & Medi | Sell | $63K | 2014-11-21 |
| Robert J. Israel | President & Medi | Sell | $68K | 2014-11-13 |
| Robert J. Israel | President & Medi | Sell | $33K | 2014-11-11 |